A. Avril

1.7k total citations
35 papers, 1.2k citations indexed

About

A. Avril is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, A. Avril has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Cancer Research and 10 papers in Pathology and Forensic Medicine. Recurrent topics in A. Avril's work include Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). A. Avril is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). A. Avril collaborates with scholars based in France, United States and Netherlands. A. Avril's co-authors include L. Mauriac, M. Durand, Jean-Marie Dilhuydy, F. Bonichon, Gaëtan MacGrogan, Anne Floquet, Marc Debled, V. Picot, G. Kantor and I. de Mascarel and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and European Journal of Cancer.

In The Last Decade

A. Avril

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Avril France 14 732 596 498 257 247 35 1.2k
Joan Jacobson United States 8 643 0.9× 382 0.6× 405 0.8× 314 1.2× 407 1.6× 12 1.1k
H.J. Dobbs United Kingdom 12 861 1.2× 502 0.8× 337 0.7× 286 1.1× 457 1.9× 23 1.5k
Marie‐Luise Sautter‐Bihl Germany 20 436 0.6× 332 0.6× 353 0.7× 291 1.1× 486 2.0× 44 1.2k
G Contesso France 10 621 0.8× 274 0.5× 454 0.9× 169 0.7× 256 1.0× 34 957
J. Hammer Austria 13 604 0.8× 303 0.5× 357 0.7× 262 1.0× 270 1.1× 36 1.1k
Jean‐Pierre Ghnassia France 12 255 0.3× 469 0.8× 167 0.3× 378 1.5× 118 0.5× 27 850
Jacques R. Vilcoq France 13 936 1.3× 520 0.9× 661 1.3× 200 0.8× 252 1.0× 14 1.3k
B. De Lafontan France 21 579 0.8× 600 1.0× 508 1.0× 233 0.9× 144 0.6× 46 1.5k
N. Pavlidis Greece 14 736 1.0× 894 1.5× 422 0.8× 442 1.7× 238 1.0× 38 1.5k
Martin Keisch United States 24 1.6k 2.2× 536 0.9× 817 1.6× 292 1.1× 672 2.7× 63 2.1k

Countries citing papers authored by A. Avril

Since Specialization
Citations

This map shows the geographic impact of A. Avril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Avril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Avril more than expected).

Fields of papers citing papers by A. Avril

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Avril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Avril. The network helps show where A. Avril may publish in the future.

Co-authorship network of co-authors of A. Avril

This figure shows the co-authorship network connecting the top 25 collaborators of A. Avril. A scholar is included among the top collaborators of A. Avril based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Avril. A. Avril is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avril, A., G. Le Bouëdec, G. Lorimier, et al.. (2011). Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up. European Journal of Surgical Oncology. 37(7). 563–570. 16 indexed citations
2.
Palussière, Jean, Antoîne Italiano, E. Descat, et al.. (2011). Sarcoma Lung Metastases Treated with Percutaneous Radiofrequency Ablation: Results from 29 Patients. Annals of Surgical Oncology. 18(13). 3771–3777. 59 indexed citations
3.
Palussière, Jean, E. Descat, Marianne Fonck, et al.. (2009). Traitement par radiofréquence des tumeurs hépatiques et pulmonaires. Bulletin du Cancer. 96(11). 1099–1109. 1 indexed citations
4.
Stoeckle, Eberhard, J.M. Coindre, Michel Longy, et al.. (2008). A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases. European Journal of Surgical Oncology. 35(2). 129–134. 89 indexed citations
5.
Lara, C. Tunon de, Gaëtan MacGrogan, M. Durand, et al.. (2008). Cancers du sein chez l’homme : à propos de 52 cas pris en charge à l’institut Bergonié de Bordeaux entre 1980 et 2004. Gynécologie Obstétrique & Fertilité. 36(4). 386–394. 15 indexed citations
6.
André, Gwenaëlle, Gaëtan MacGrogan, Frédérique Valentin, et al.. (2007). Carcinomes canalaires in situ bilatéraux: événements indépendants ou maladie bilatérale?. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 36(3). 260–266. 2 indexed citations
7.
Stoeckle, E., G. Kantor, F. Bonichon, et al.. (2006). Prospective evaluation of quality of surgery in soft tissue sarcoma. European Journal of Surgical Oncology. 32(10). 1242–1248. 62 indexed citations
8.
Lara, C. Tunon de, Gaëtan MacGrogan, E Bussières, et al.. (2004). Sarcomes primitifs du sein. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 33(7). 589–599. 5 indexed citations
9.
MacGrogan, Gaëtan, P. Rudolph, I. de Mascarel, et al.. (2003). DNA topoisomerase IIα expression and the response to primary chemotherapy in breast cancer. British Journal of Cancer. 89(4). 666–671. 78 indexed citations
10.
11.
Bijker, Nina, Johannes L. Peterse, Ian S. Fentiman, et al.. (2002). Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS. British Journal of Cancer. 87(6). 615–620. 36 indexed citations
12.
MacGrogan, Gaëtan, A Faucher, E Bussières, et al.. (2001). Analysis of 676 Cases of Ductal Carcinoma in Situ of the Breast From 1971 to 1995. American Journal of Clinical Oncology. 24(6). 531–536. 31 indexed citations
13.
Mauriac, L., Gaëtan MacGrogan, A. Avril, et al.. (1999). Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up. Annals of Oncology. 10(1). 47–52. 352 indexed citations
14.
Mascarel, I. de, F. Bonichon, M. Durand, et al.. (1998). Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers. European Journal of Cancer. 34(1). 58–65. 72 indexed citations
15.
Mauriac, L., M. Durand, A. Avril, & Jean-Marie Dilhuydy. (1991). Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Annals of Oncology. 2(5). 347–354. 228 indexed citations
16.
Mauriac, L., M. Durand, J Chauvergne, et al.. (1988). Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF+ tamoxifen in a single centre. Breast Cancer Research and Treatment. 11(2). 179–186. 16 indexed citations
17.
Bussières, E, et al.. (1988). [Urinary complications and disorders of pelvic statics after abdominoperineal amputation of the rectum].. PubMed. 42(1). 22–7. 3 indexed citations
18.
Avril, A., F. Bonichon, Marion Durand, et al.. (1986). [Prognostic significance of isolated local recurrences in breast cancer following mastectomy and axillary node excision. Apropos of 77 recurrences in 2362 patients].. PubMed. 73(5). 497–503. 1 indexed citations
19.
Avril, A., et al.. (1981). [Randomized trial with tiapride in post-operative care (author's transl)].. PubMed. 35(1). 62–4. 2 indexed citations
20.
Chauvergne, J, et al.. (1974). Fe-Cr-Al 合金の異常酸化に及ぼす表面性状の影響. PubMed. 10(1). 637–646. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joan Jacobson Breakdown of academic impact, for papers by H.J. Dobbs Breakdown of academic impact, for papers by Marie‐Luise Sautter‐Bihl Breakdown of academic impact, for papers by G Contesso Breakdown of academic impact, for papers by J. Hammer Breakdown of academic impact, for papers by Jean‐Pierre Ghnassia Breakdown of academic impact, for papers by Jacques R. Vilcoq Breakdown of academic impact, for papers by B. De Lafontan Breakdown of academic impact, for papers by N. Pavlidis Breakdown of academic impact, for papers by Martin Keisch
Rankless by CCL
2026